Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eli Lilly: If at First You Don't Succeed... (video)
Motley Fool
Saturday, December 15, 2012 - 12:55pm
tags:
Eli Lilly, Alzheimer's disease
Aegerion Hits New High
Motley Fool
Saturday, December 15, 2012 - 12:54pm
tags:
Aegerion, lomitapide, Homozygous Familial Hypercholesterolemia, cholesterol
Big Yields in Drug Land
Motley Fool
Saturday, December 15, 2012 - 12:53pm
tags:
Pfizer, Merck, JNJ, AstraZeneca, Eli Lilly, Bristol-Myers Squibb, PDL Biopharma
Eliqius A Huge Growth Catalyst For Bristol-Myers Squibb
Seeking Alpha
Saturday, December 15, 2012 - 12:51pm
tags:
Eliqius, anti-clotting
Isis Pharma, AstraZeneca Ink Deal
Yahoo/Zacks
Saturday, December 15, 2012 - 12:49pm
tags:
Isis Pharmaceuticals, AstraZeneca, ISIS-STAT3Rx, lymphoma
GlaxoSmithKline’s New Drug Has Anthrax Under Control
Wall Street Cheat Street
Saturday, December 15, 2012 - 12:48pm
tags:
GSK, anthrax, raxibacumab
The Pipeline Powerhouse You Can't Afford To Miss
Seeking Alpha
Saturday, December 15, 2012 - 12:48pm
tags:
Pfizer
AstraZeneca's RA Drug Disappoints
Yahoo/Zacks
Saturday, December 15, 2012 - 12:43pm
tags:
AstraZeneca, rheumatoid arthritis, fostamatinib, Rigel Pharmaceuticals
How Merck Beat Its Patent Cliff
Motley Fool
Saturday, December 15, 2012 - 12:42pm
tags:
Merck
RNA Technology Could Save Lives, Create Investment Opportunity
Motley Fool
Saturday, December 15, 2012 - 12:33pm
tags:
JNJ, Zytiga, Dendreon, Provenge
Medical Stocks That Can Make You Sleep
Motley Fool
Saturday, December 15, 2012 - 11:36am
tags:
insomnia, hypnotics, Silenor, Somaxon, Pernix Therapeutics Holdings, Intermezzo, Transcept
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, December 15, 2012 - 11:33am
tags:
YM BioSciences, Gilead Sciences, M&A, Infinity Pharmaceuticals, Synta Pharmaceuticals
Sequenom Provides Update On Status Of Patent For Methods Of Detecting Fetal Aneuploidy
Yahoo/PR Newswire
Saturday, December 15, 2012 - 11:31am
tags:
Sequenom, Fetal Aneuploidy
Why Ariad Pharmaceuticals' Shares Dropped
Motley Fool
Saturday, December 15, 2012 - 11:30am
tags:
Ariad Pharmaceuticals, Iclusig, chronic myeloid leukemia, leukemia, acute lymphoblastic leukemia
Big News for This Blockbuster Drug
Motley Fool
Saturday, December 15, 2012 - 11:27am
tags:
JNJ, Zytiga, prostate cancer
Ariad Sinks on Safety Warnings With U.S. Drug Approval
Bloomberg
Saturday, December 15, 2012 - 11:25am
tags:
Ariad Pharmaceuticals, Iclusig, leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia
Vertex Pharmaceuticals Larger Than S&P 500 Component Noble Corp
Forbes
Saturday, December 15, 2012 - 11:23am
tags:
Vertex Pharmaceuticals
Gilead Sciences' Stock Dividend And What's Behind It
Seeking Alpha
Saturday, December 15, 2012 - 11:23am
tags:
Gilead Sciences
Grab This Deal Even Lower Than CEO and President Lichtinger Did
Forbes
Saturday, December 15, 2012 - 11:22am
tags:
Optimer Pharmaceuticals
CEL-SCI Corporation Announces Fiscal 2012 Financial Results
Yahoo/BusinessWire
Saturday, December 15, 2012 - 11:21am
tags:
Cel-Sci, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.